Tori Marsh - June 14, 2018
Brand drugs are expensive — this we already know, and prices seem to only be increasing. Of the 100 most-prescribed brand-name medications, those for diabetes, rheumatoid arthritis, and Crohn’s disease tend to be the most expensive. All of the drugs on this list are brand-only medications, meaning that there are no affordable generic alternatives available.
Additionally, it can be difficult for people to receive adequate insurance coverage for many of these drugs as they may be placed in more expensive, higher-tier formularies or have some other coverage restrictions. See More
Benita Lee - June 13, 2018
Botox. Humira. Lantus. Enbrel. You’ve probably heard of at least one of these medicines before, but did you know that all of them are derived from living cells? These popular drugs are examples of biologics, or biological medications, that are developed from blood, proteins, viruses, and living organisms and are used to prevent, treat, and cure human disease.
How are biologics different from other drugs?
Marie Beaugureau - December 19, 2017
In 2015, Americans spent $1,200 per capita on prescription medications, the highest rate in the world. In the U.S. a 30-day prescription to Xarelto (used to treat blood clots) costs $292, on average – where that same prescription costs just $126 in the UK, $102 in Switzerland, and just $48 in South Africa, according to a 2016 survey by the International Federation of Health Plans. A 28-day supply of Humira, used for Crohn’s disease and rheumatoid arthritis, costs a whopping $2,669 in the US – but just $822 in Switzerland and $1,362 in the UK. See More
Roni Shye - September 14, 2017
What is a biosimilar?
Without getting too technical, biosimilars are basically the generic product of a biologic (a medication made from a living organism). However, because these medications are made out of living cells they are slightly different. See More
Roni Shye - September 28, 2016
We have good news for your health wallet! Humira (adalimumab), a popular specialty medication used to treat rheumatoid and psoriatic arthritis, will soon have a less expensive alternative, Amjevita (adalimumab-atto).
Amjevita is a “biosimilar” to Humira (because biologic drugs like Humira can’t have traditional generic alternatives), and will be offered at a reduced cost. Amjevita is now the 1st FDA approved biosimilar for Humira, the 2nd biggest selling drug of 2015. See More
Dr. Sharon Orrange - June 03, 2015
In the last decade, billions of dollars have been spent to develop hundreds of new prescription drugs. While some drugs may not necessarily save lives (a prescription for longer eyelashes, anyone?), a handful of drugs have literally stopped major diseases in their tracks. Imagine that just ten years ago a patient might not be alive months or years after a diagnosis, whereas today a simple pill can cure or prevent a deadly disease. See More
Roni Shye - March 24, 2015
When you pick up your medications at the pharmacy you may notice that they are typically dispensed in amber colored vials or plastic containers. You may or may not be aware that these amber colored vials are not the original bottle the manufacturer dispensed the medication in.
For the majority of medications, transferring them from the manufacturer’s original bottle to the pharmacy’s amber vials is not a big deal, and lets the pharmacy purchase in bulk (which is more cost-effective)—unless you are taking certain medications. See More
Roni Shye - December 30, 2014
You may be unfamiliar with the terms biologics or biosimilars but if you watch television you may have seen a commercial for them and not even know it! For example – the popular arthritis or Crohn’s medications Enbrel and Humira are biologics.
Biologics are medications that are typically expensive and usually obtained from a specialty pharmacy. Biologics are generally not used as first line treatment but instead considered by your doctor after other less expensive treatment options have been tried and failed. See More
Roni Shye - September 19, 2014
A 2014 comes to a close, we should be thinking about what to expect for 2015. The start of a new year is a time for new challenges, new goals, and inevitably, a new prescription formulary.
What does this mean for you?
Express Scripts has actually decided to add a medication back to their national preferred formulary. When it comes to drugs that treat inflammatory conditions like arthritis, psoriasis, and ulcerative colitis, you’ll actually have another option this year. See More
Roni Shye - November 13, 2013
Express Scripts and Caremark have removed certain medications from their formulary starting in January 2014. These companies handle prescription benefits for more than 200 million Americans, so your prescription coverage will likely be changing in the new year.
Over the next couple of weeks, we’ll be reviewing which prescriptions will no longer be covered and the suggested alternatives to give you a better picture of your options. See More